IL-4 in the Brain: A Cytokine To Remember
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cohen, 2006, Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells., J. Neurobiol., 66, 552, 10.1002/neu.20249
Ziv, 2006, Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood., Nat. Neurosci., 9, 268, 10.1038/nn1629
Brynskikh, 2008, Adaptive immunity affects learning behavior in mice., Brain Behav. Immun., 22, 861, 10.1016/j.bbi.2007.12.008
Engelhardt, 2005, The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms., Trends Immunol., 26, 485, 10.1016/j.it.2005.07.004
Derecki, 2010, Regulation of learning and memory by meningeal immunity: a key role for IL-4., J. Exp. Med., 207, 1067, 10.1084/jem.20091419
Howard, 1982, Identification of a T cell-derived b cell growth factor distinct from interleukin 2., J. Exp. Med., 155, 914, 10.1084/jem.155.3.914
Hu-Li, 1987, B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes., J. Exp. Med., 165, 157, 10.1084/jem.165.1.157
Minshall, 1997, IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors., J. Immunol., 159, 1225, 10.4049/jimmunol.159.3.1225
Seder, 1992, The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice., J. Exp. Med., 176, 1091, 10.1084/jem.176.4.1091
Hsieh, 1992, Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system., Proc. Natl. Acad. Sci. USA, 89, 6065, 10.1073/pnas.89.13.6065
Geha, 2003, The regulation of immunoglobulin E class-switch recombination., Nat. Rev. Immunol., 3, 721, 10.1038/nri1181
Wills-Karp, 2011, Innate lymphoid cells wield a double-edged sword., Nat. Immunol., 12, 1025, 10.1038/ni.2142
Nelms, 1999, The IL-4 receptor: signaling mechanisms and biologic functions., Annu. Rev. Immunol., 17, 701, 10.1146/annurev.immunol.17.1.701
Callard, 1996, IL-4 and IL-13 receptors: are they one and the same?, Immunol. Today, 17, 108, 10.1016/0167-5699(96)80600-1
Ramalingam, 2008, Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain., Nat. Immunol., 9, 25, 10.1038/ni1544
Goenka, 2011, Transcriptional regulation by STAT6., Immunol. Res., 50, 87, 10.1007/s12026-011-8205-2
Lee, 2003, Regulation of the Th2 cytokine locus by a locus control region., Immunity, 19, 145, 10.1016/S1074-7613(03)00179-1
Luzina, 2012, Regulation of inflammation by interleukin-4: a review of “alternatives.”, J. Leukoc. Biol, 10.1189/jlb.0412214
Kipnis, 2004, T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions., Proc. Natl. Acad. Sci. USA, 101, 8180, 10.1073/pnas.0402268101
Hess, 2007, Chemotherapy-related change in cognitive function: a conceptual model., Oncol. Nurs. Forum, 34, 981, 10.1188/07.ONF.981-994
Wolf, 2009, CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis., J. Immunol., 182, 3979, 10.4049/jimmunol.0801218
Morris, 1984, Developments of a water-maze procedure for studying spatial learning in the rat., J. Neurosci. Methods, 11, 47, 10.1016/0165-0270(84)90007-4
Wolf, 2009, Adaptive peripheral immune response increases proliferation of neural precursor cells in the adult hippocampus., FASEB J., 23, 3121, 10.1096/fj.08-113944
Gage, 1995, Isolation, characterization, and use of stem cells from the CNS., Annu. Rev. Neurosci., 18, 159, 10.1146/annurev.ne.18.030195.001111
Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain., Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297
Couthouis, 2011, A yeast functional screen predicts new candidate ALS disease genes., Proc. Natl. Acad. Sci. USA, 108, 20881, 10.1073/pnas.1109434108
Kelley, 2003, Cytokine-induced sickness behavior., Brain Behav. Immun., 17, S112, 10.1016/S0889-1591(02)00077-6
Choy, 2008, Combined neonatal stress and young-adult glucocorticoid stimulation in rats reduce BDNF expression in hippocampus: effects on learning and memory., Hippocampus, 18, 655, 10.1002/hipo.20425
Hall, 2000, Rapid and selective induction of BDNF expression in the hippocampus during contextual learning., Nat. Neurosci., 3, 533, 10.1038/75698
Schwartz, 2010, “Tissue-repairing” blood-derived macrophages are essential for healing of the injured spinal cord: from skin-activated macrophages to infiltrating blood-derived cells?, Brain Behav. Immun., 24, 1054, 10.1016/j.bbi.2010.01.010
Derecki, 2011, Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice., Brain Behav. Immun., 25, 379, 10.1016/j.bbi.2010.11.009
Hart, 1989, Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2., Proc. Natl. Acad. Sci. USA, 86, 3803, 10.1073/pnas.86.10.3803
Major, 2002, IL-4 pretreatment selectively enhances cytokine and chemokine production in lipopolysaccharide-stimulated mouse peritoneal macrophages., J. Immunol., 168, 2456, 10.4049/jimmunol.168.5.2456
Milner, 2010, Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation., Blood, 116, 2476, 10.1182/blood-2009-11-255174
Brodie, 1998, Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion., J. Neuroimmunol., 81, 20, 10.1016/S0165-5728(97)00154-9
Awatsuji, 1993, Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes., J. Neurosci. Res., 34, 539, 10.1002/jnr.490340506
Gow, 2010, CSF-1, IGF-1, and the control of postnatal growth and development., J. Leukoc. Biol., 88, 475, 10.1189/jlb.0310158
Liu, 2000, In vivo expression of the interleukin 4 receptor alpha by astrocytes in epilepsy cerebral cortex., Cytokine, 12, 1656, 10.1006/cyto.2000.0773
Hu, 1995, Differential regulation by cytokines of human astrocyte nitric oxide production., Glia, 15, 491, 10.1002/glia.440150412
Pousset, 1999, Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study., Glia, 26, 12, 10.1002/(SICI)1098-1136(199903)26:1<12::AID-GLIA2>3.0.CO;2-S
Garg, 2009, IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes., J. Neurochem., 108, 1155, 10.1111/j.1471-4159.2009.05872.x
Alliot, 1999, Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain., Brain Res. Dev. Brain Res., 117, 145, 10.1016/S0165-3806(99)00113-3
Mildner, 2007, Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions., Nat. Neurosci., 10, 1544, 10.1038/nn2015
Michelucci, 2009, Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta., J. Neuroimmunol., 210, 3, 10.1016/j.jneuroim.2009.02.003
Ponomarev, 2007, CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells., J. Neurosci, 27, 10714, 10.1523/JNEUROSCI.1922-07.2007
Chao, 1995, Modulation of human microglial cell superoxide production by cytokines., J. Leukoc. Biol., 58, 65, 10.1002/jlb.58.1.65
Butovsky, 2005, Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective., Mol. Cell. Neurosci., 29, 381, 10.1016/j.mcn.2005.03.005
Suzumura, 1994, Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression., J. Neuroimmunol., 53, 209, 10.1016/0165-5728(94)90031-0
Lyons, 2009, Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide., Brain Behav. Immun., 23, 1020, 10.1016/j.bbi.2009.05.060
Butovsky, 2006, Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells., Mol. Cell. Neurosci., 31, 149, 10.1016/j.mcn.2005.10.006
Butovsky, 2007, Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers., Mol. Cell. Neurosci., 35, 490, 10.1016/j.mcn.2007.04.009
Verbitsky, 2004, Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice., Learn. Mem., 11, 253, 10.1101/lm.68204
Zahn, 2007, AGEMAP: a gene expression database for aging in mice., PLoS Genet., 3, e201, 10.1371/journal.pgen.0030201
Lynch, 2010, Age-related neuroinflammatory changes negatively impact on neuronal function, Front. Aging Neurosci., 1, 6, 10.3389/neuro.24.006.2009
Bellinger, 1993, Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus., Brain Res., 628, 227, 10.1016/0006-8993(93)90959-Q
Curran, 2001, The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro., Neuroscience, 108, 83, 10.1016/S0306-4522(01)00405-5
Maher, 2005, Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat., Neurobiol. Aging, 26, 717, 10.1016/j.neurobiolaging.2004.07.002
Nolan, 2005, Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus., J. Biol. Chem., 280, 9354, 10.1074/jbc.M412170200
Fenn, 2012, Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice., Brain Behav. Immun., 26, 766, 10.1016/j.bbi.2011.10.003
Griffin, 2006, The age-related attenuation in long-term potentiation is associated with microglial activation., J. Neurochem., 99, 1263, 10.1111/j.1471-4159.2006.04165.x
Kitazawa, 2011, Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer’s disease model., J. Immunol., 187, 6539, 10.4049/jimmunol.1100620
Abbas, 2002, Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice., J. Neuroimmunol., 126, 50, 10.1016/S0165-5728(02)00050-4
Kiyota, 2010, CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer’s disease-like pathogenesis in APP+PS1 bigenic mice., FASEB J., 24, 3093, 10.1096/fj.10-155317
Jimenez, 2008, Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer’s disease: age-dependent switch in the microglial phenotype from alternative to classic., J. Neurosci., 28, 11650, 10.1523/JNEUROSCI.3024-08.2008
Walker, 2009, Decreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation., Exp. Neurol., 215, 5, 10.1016/j.expneurol.2008.09.003
Lyons, 2007, CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4., J. Neurosci., 27, 8309, 10.1523/JNEUROSCI.1781-07.2007
Koning, 2010, Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation., J. Innate Immun., 2, 195, 10.1159/000252803
Shimizu, 2008, IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia., J. Immunol., 181, 6503, 10.4049/jimmunol.181.9.6503
Yamamoto, 2008, Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes., J. Immunol., 181, 3877, 10.4049/jimmunol.181.6.3877
Cao, 2009, Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer’s mice without infiltrating the CNS., Neurobiol. Dis., 34, 63, 10.1016/j.nbd.2008.12.015
Falcone, 1998, A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice., J. Immunol., 160, 4822, 10.4049/jimmunol.160.10.4822
Hulshof, 2002, Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions., Glia, 38, 24, 10.1002/glia.10050
Mikita, 2011, Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration, Mult. Scler., 17, 2, 10.1177/1352458510379243
Butovsky, 2006, Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis., J. Clin. Invest., 116, 905, 10.1172/JCI26836
Qin, 2012, Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation., Proc. Natl. Acad. Sci. USA, 109, 5004, 10.1073/pnas.1117218109
Bondy, 2008, Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium., Cancer, 113, 1953, 10.1002/cncr.23741
Olver, 2007, The duplicitous effects of interleukin 4 on tumour immunity: how can the same cytokine improve or impair control of tumour growth?, Tissue Antigens, 69, 293, 10.1111/j.1399-0039.2007.00831.x
Debinski, 2000, Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen., Mol. Med., 6, 440, 10.1007/BF03401786
Puri, 1994, Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein., Int. J. Cancer, 58, 574, 10.1002/ijc.2910580421
Joshi, 2001, In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures., Cancer Res., 61, 8058
Brenner, 2002, History of allergies and autoimmune diseases and risk of brain tumors in adults., Int. J. Cancer, 99, 252, 10.1002/ijc.10320
Wiemels, 2002, History of allergies among adults with glioma and controls., Int. J. Cancer, 98, 609, 10.1002/ijc.10239
Schwartzbaum, 2005, Polymorphisms associated with asthma are inversely related to glioblastoma multiforme., Cancer Res., 65, 6459, 10.1158/0008-5472.CAN-04-3728
Ruan, 2011, Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma., Front Biosci (Elite Ed), 3, 33
Scheurer, 2008, Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma, Clin. Cancer Res, 14, 6640, 10.1158/1078-0432.CCR-07-4681
Saleh, 1997, The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium., Int. J. Cancer, 72, 664, 10.1002/(SICI)1097-0215(19970807)72:4<664::AID-IJC19>3.0.CO;2-B
Topp, 1995, Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies., Cancer Res., 55, 2173
Benedetti, 1999, Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene., Cancer Res., 59, 645
Post, 2007, Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4., Cancer Res., 67, 6872, 10.1158/0008-5472.CAN-06-3244
Cherry, 2010, Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy., Gene Ther., 17, 1430, 10.1038/gt.2010.100
Volpert, 1998, Inhibition of angiogenesis by interleukin 4., J. Exp. Med., 188, 1039, 10.1084/jem.188.6.1039
Tepper, 1992, An eosinophil-dependent mechanism for the antitumor effect of interleukin-4., Science, 257, 548, 10.1126/science.1636093
Curran, 2012, Eosinophils in glioblastoma biology., J. Neuroinflammation, 9, 11, 10.1186/1742-2094-9-11
Gocheva, 2010, IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion., Genes Dev., 24, 241, 10.1101/gad.1874010
Mantovani, 2010, Macrophages, innate immunity and cancer: balance, tolerance, and diversity., Curr. Opin. Immunol., 22, 231, 10.1016/j.coi.2010.01.009
Linde, 2012, Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages., J. Pathol., 227, 17, 10.1002/path.3989
Stellwagen, 2006, Synaptic scaling mediated by glial TNF-alpha., Nature, 440, 1054, 10.1038/nature04671